Stock info Revenio Group | Filter  Basic-Info

Revenio Group

The past year was a relatively good year for Revenio Group investors

The period between December 2015 and December 2016 was a good period for the investors. The stock gained almost 7 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 612 percent. Revenio Group's revenues between 2011 and 2015 were very constant and moved between 25,38 million euros and 20,25 million euros. Revenio Group's net incomes between 2011 and 2015 were very volatile through the time and moved between 2,18 million euros and 4,59 million euros.

Revenio Group has her headquarter located in Vantaa. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The Finnish company paid out dividends in the past 5 years. On average the Revenio Group stock yielded a delivered a dividend yield of around 1,7 percent over the past 5 years.

At the end of 2015 around 2822 thousand people were employed at Revenio Group.

Revenio Group financed with lots of debt

At the end of 2015 the pharmaceutical company's balance sheet was worth 18,43 million euros. Last year the total debt of the company was 2,88 million euros. This equals around 15,63 percent of the total balance sheet. At the end of 2016 the Finnish company was traded with a price/earnings-ratio of around 24. So investors paid 24 times the company's 2015's EPS. Based on the classical stock valuation theories the Finnish stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 227,07 million euros. At the end of 2015 the Finnish company had around 7,94 million stocks listed.

All Revenio Group's financial reports are available here. More information about Revenio Group can be found it's website. .